LTX-315, an oncolytic peptide, to convert immunogenically 'cold' tumors to 'hot' in patients with advanced or metastatic tumours: Results from an ongoing phase I study.

被引：5
|
作者：
Spicer, James F.
Baurain, Jean -Francois
Awada, Ahmad
Kristeleit, Rebecca Sophie
Jossang, Dag Erik
Marabelle, Aurelien
Loirat, Delphine
Wold, Hedda
Nicolaisen, Berit
Rekdal, Oystein
Olsen, Wenche Marie
Saunders, Andrew
Brunsvig, Paal
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3085
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Safety and tolerability of intratumorally administered OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: A phase I dose escalation clinical study.
    Huang, Jing
    Zhang, Bo
    Tang, Jialin
    Chang, Qing
    Zhang, Rui
    Geng, Chengyun
    Wu, Dawei
    Qi, Ling
    Gu, Xiangyong
    Liu, Binlei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Epacadostat plus durvalumab in patients with advanced solid tumors: preliminary results of the ongoing, open-label, phase I/II ECHO-203 study
    Naing, Aung
    Powderly, John D.
    Falchook, Gerald
    Creelan, Benjamin
    Nemunaitis, John
    Lutzky, Jose
    Diab, Adi
    Wang, Judy S.
    Laing, Naomi
    Niewood, Michelle
    Gong, Xiaohua
    Zhou, Gongfu
    Patel, Manish
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Sacituzumab govitecan (SG) in patients (pts) with previously treated metastatic endometrial cancer (mEC): results from a phase I/II study.
    Santin, Alessandro
    Komiya, Takefumi
    Goldenberg, David M.
    Sharkey, Robert M.
    Hong, Quan
    Wegener, William A.
    Goswami, Trishna
    Bardia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] INVAC-1, an optimized telomerase DNA vaccine in patients with advanced solid tumors: Final results of first-in-human phase I study.
    Garibal, Julie
    Medioni, Jacques
    Teixeira, Luis
    Adotevi, Olivier
    Dragon-Durey, Marie-Agnes
    Laheurte, Caroline
    Germain, Claire
    Escande, Marie
    Wehbe, Maria
    Doppler, Valerie
    Huet, Thierry
    Demoyen, Pierre Langlade
    CANCER RESEARCH, 2021, 81 (13)
  • [25] TQB2450 in patients with advanced malignant tumors: results from a phase I dose-escalation and expansion study
    Xue, Junli
    Xue, Liqiong
    Tang, Wenbo
    Ge, Xiaoxiao
    Zhao, Wei
    Li, Qun
    Peng, Wei
    Dai, Congqi
    Guo, Ye
    Li, Jin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [26] Tislelizumab in combination with chemotherapy in Chinese patients with advanced gastric or gastroesophageal junction (G/GEJ) cancer: Results from one cohort of an ongoing phase 2 study.
    Bai, Yu-Xian
    Li, En Xiao
    Wang, Buhai
    Yuan, Xianglin
    Xu, Nong
    Chen, Yunxin
    Li, Xiang
    Wang, Huanli
    Xu, Jianming
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [27] Selinexor in combination with weekly paclitaxel in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multiarm phase 1b study.
    Westin, Shannon Neville
    Fu, Siqing
    Tsimberidou, Apostolia Maria
    Piha-Paul, Sarina Anne Anne
    Akhmedzhanov, Fechukwu
    Yilmaz, Bulent
    McQuinn, Lacey
    Brink, Amanda L.
    Gong, Jing
    Leung, Cheuk Hong
    Lin, Heather Y.
    Hong, David S.
    Pant, Shubham
    Jazaeri, Amir A.
    Gershenson, David Marc
    Sood, Anil K.
    Coleman, Robert L.
    Shah, Jatin J.
    Meric-Bernstam, Funda
    Naing, Aung
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Clinical and pharmacokinetic study with liposomal doxorubicin (DL-1) in patients with advanced metastatic cancer -: results from a phase-I study
    Mross, K
    Gierlich, T
    Häring, B
    März, W
    Unger, C
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2002, 40 (08) : 387 - 388
  • [29] Novel 2-step desensitization dosing regimen of intravenous PV701, an oncolytic virus, results in improved tolerability: a phase I study of patients with advanced solid tumours
    Laurie, SA
    Atkins, HL
    Bell, JC
    Roach, J
    Maroun, JA
    Bamat, MK
    Rheaume, N
    Lorence, RM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S155 - S155
  • [30] GFH018, a small molecular inhibitor targeting TGF-βRI kinase, in patients with advanced solid tumors: Final results of the phase I study.
    Guo, Ye
    Wang, Zishu
    Zhou, Huan
    Pan, Hongming
    Han, Weidong
    Deng, Yanhong
    Zhang, Yanqiao
    Zhang, Yue
    Wang, Shuang
    Wang, Jing
    Zhu, Huaqiang
    Shen, Haige
    Wang, Yu
    Li, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345